
معرفی
Didier Hans is Associate Professor in Research and Development in the field of bone diseases at the Faculty of Biology and Medicine of the University of Lausanne (UNIL) and Head of the CHUV Bone Disease Center, appointed on December 1, 2012. He holds an 80% activity rate, indicating a part-time academic role. His work bridges academic research, clinical innovation, and industrial development in medical imaging for bone disorders.
- PhD in Medical Physics, Claude Bernard University, Lyon (1993)
- Master of Science in Medical Engineering, Claude Bernard University, Lyon (1991)
- Executive Master of Business Administration, Haute École Commerciale de l'Université de Genève (2004)
Didier Hans specializes in medical imaging applied to bone diseases, particularly osteoporosis and fracture risk assessment. His research focuses on two main axes: validating new imaging technologies and developing clinical algorithms to improve patient care. He is a world leader in clinical densitometry and bone microarchitecture analysis, with over 160 publications and leadership in international research collaborations.
The recent articles reflect a strong trend in translational research, combining engineering, physics, and clinical medicine. Key areas include optimization of bone measurement technologies, integration of imaging into multidisciplinary platforms, and development of risk prediction models using large cohort data (OstéoLaus, Ostéomobile). His work spans technology validation, clinical implementation, and educational standardization through global societies.
Scientific awards and leadership roles include:
- President of the International Society for Clinical Densitometry (ISCD) – first non-North American and non-physician in this role
- Initiator of collaboration between ISCD and International Osteoporosis Foundation for unified teaching
- Founder of Synarc, now the world’s largest centralized imaging analysis lab for clinical trials
- Founder of two companies: Med-imaps and Ascendys
- Privat-docent at the Faculty of Medicine, University of Geneva (later transferred to UNIL)
Didier Hans has advised numerous scientific collaborations worldwide, with over 50 ongoing studies. His grants and research projects focus on optimizing bone and body composition measurements across macro and micro levels. He leads R&D at the CHUV Bone Disease Center and has played a key role in expanding clinical activity and patient care models since 2008.
He leads the OstéoLaus and Ostéomobile research cohorts, involving over 3,000 women, which serve as critical platforms for longitudinal bone health research. His multidisciplinary team integrates expertise from radiology, nuclear medicine, engineering, and data science to advance diagnostics and personalized care in bone diseases.





